Posters

17 10, 2025

Poster Presentation: Digitally Secure Sequencing – Implementing Part 11 Ready NGS Data Security in a CRO Environment
Gallery

Poster Presentation: Digitally Secure Sequencing – Implementing Part 11 Ready NGS Data Security in a CRO Environment

webmaster2025-12-23T18:19:28+00:00

Next- and third-generation sequencing are vital for GMP, GLP, and clinical applications, but data integrity challenges and 21 CFR Part 11 compliance require secure instruments, validated workflows, and robust audit trails...

Poster Presentation: Digitally Secure Sequencing – Implementing Part 11 Ready NGS Data Security in a CRO Environmentwebmaster2025-12-23T18:19:28+00:00

17 10, 2025

Poster Presentation: Genome-wide Mapping of CRISPR-Cas Off-Target Cleavage Sites via GUIDE-Seq
Gallery

Poster Presentation: Genome-wide Mapping of CRISPR-Cas Off-Target Cleavage Sites via GUIDE-Seq

webmaster2025-12-23T18:19:46+00:00

Genome editing offers unprecedented precision, but off-target effects remain a key safety concern. GUIDE-Seq provides a high-throughput, genome-wide method to map CRISPR-Cas activity in living cells, enabling researchers to assess specificity and ensure safer gene-editing therapies...

Poster Presentation: Genome-wide Mapping of CRISPR-Cas Off-Target Cleavage Sites via GUIDE-Seqwebmaster2025-12-23T18:19:46+00:00

Avance Biosciences to Exhibit at Festival of Biologics USA 2026

FDA Increases Flexibility on CMC Requirements for Cell and Gene Therapies to Advance Innovation

How Consistent Assay Performance Reduces Batch Failures

What PERT Signals About the Future of Gene Editing Manufacturing and Regulation

What “Fit-for-Purpose” Really Means in Bioanalytical Method Development

New FDA Final Guidance on Development of Therapeutic Protein Biosimilars: Analytical Considerations for Biologics Developers